Citadel Advisors »

Vistagen Therapeutics Ord shares owned by Citadel Advisors

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.2M 817k 5.14
2023-09-30 $358k 68k 5.24
2023-06-30 $37k 20k 1.87

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Vanguard Group
Commodore Capital
Citadel Advisors
Sphera Funds Management
Susquehanna International
BlackRock
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
Gts Securities

View all funds holding Vistagen Therapeutics Ord